BIT 3.23% 3.0¢ biotron limited

Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR, page-30

  1. 13,815 Posts.
    lightbulb Created with Sketch. 2340
    Maybe they don't want a longer time for people to think of difficult questions.

    Does have the feel of an exercise to drum up support before a CR announcement - and before the EOFY cash flow statements and auditors report.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.